Clindamycin Hydrochloride recalls
Clindamycin Hydrochloride products have been recalled 2 times, most recently on 16 Apr 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing1latest 16 Apr 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why clindamycin hydrochloride is recalled
Companies
Product types
By year
Ongoing clindamycin hydrochloride recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Hydrochloride Capsules, USP, 300mg recalledClindamycin Hydrochloride | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |
All clindamycin hydrochloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Hydrochloride Capsules, USP, 300mg recalledClindamycin Hydrochloride | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Clindamycin Hydrochloride Capsules, USP,150mg recalledClindamycin Hydrochloride | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.